Microsoft is enforcing stricter Intune MAM security requirements, and enterprises that haven’t updated their iOS and Android ...

COPENHAGEN, Denmark, Jan. 15, 2026 /PRNewswire/ -- CapaSystems A/S, a European leader in endpoint management and cyber security innovation with more than 30 years of experience, today announced the ...

The FDA’s oversight of medical device recalls continues to be plagued by staffing challenges—forcing some activities to be placed on the “back burner” and resulting in lengthy response times, ...

In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Kimberly Blakemore, head of ADVentures, said that Niobium ...

Abstract: The proliferation of counterfeit and refurbished semiconductor devices has become a critical concern. Device identification techniques based on Physically Unclonable Functions (PUFs) have ...

The U.S. Food and Drug Administration has issued an alert for “a potentially high-risk issue” regarding two glucose monitor sensors that have been malfunctioning and linked to multiple fatalities. The ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min ADVentures, based in the Boston ...

Microsoft is bringing advanced endpoint management capabilities from its Intune Suite directly into Microsoft 365 E3 and E5 subscriptions, the company announced this week, expanding access to tools ...

Patients are being warned to stop using some glucose monitors made by Abbott Diabetes Care after the company found malfunctioning sensors may be linked to hundreds of adverse events and several deaths ...

Malfunctioning glucose trackers made by Abbott Diabetes Care have been linked to more than 700 severe adverse events and seven potential deaths, the Food and Drug Administration (FDA) and Abbott said.

Johnson & Johnson is facing lawsuits stemming from the recall of some of its Linx reflux management devices for a manufacturing defect, highlighting the risks that come from such recalls. The Linx ...